A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment - Woodruff, S; Feugère, G; Abreu, P; Heissler, J; Ruiz, M T; Jen, F (J Thromb Thrombolysis, 2016)